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Position-specific entropy profiles created from scan-
ning 306 human and 95 avian influenza A viral genomes
showed that 228 of 4,591 amino acid residues yielded sig-
nificant differences between these 2 viruses. We subse-
quently used 15,785 protein sequences from the National
Center for Biotechnology Information (NCBI) to assess the
robustness of these signatures and obtained 52 “species-
associated” positions. Specific mutations on those points
may enable an avian influenza virus to become a human
virus. Many of these signatures are found in NP, PA, and
PB2 genes (viral ribonucleoproteins [RNPs]) and are most-
ly located in the functional domains related to RNP-RNP
interactions that are important for viral replication. Upon
inspecting 21 human-isolated avian influenza viral
genomes from NCBI, we found 19 that exhibited >1
species-associated residue changes; 7 of them contained
>2 substitutions. Histograms based on pairwise sequence
comparison showed that NP disjointed most between
human and avian influenza viruses, followed by PA and
PB2.
P
andemic influenza A virus infections have occurred 3
times during the past century; the 1957 (H2N2) and
1968 (H3N2) pandemic strains emerged from a reassort-
ment of human and avian viruses (1). Recently, all 8
genome segments from the 1918 (H1N1) influenza Avirus
were completely sequenced. The results indicate that the
1918 pandemic virus may not have emerged by a reassort-
ment of avian and human virus as did the 2 other pandem-
ic strains. Although the 1918 H1N1 is not considered an
avian virus, it is the most avianlike of all mammalian
influenza viruses (2,3). The recent circulation of highly
pathogenic avian H5N1 viruses in Asia from 2003 to 2006
has caused >90 human deaths and has raised concern about
a new pandemic (4). Therefore, we need to understand
what genetic variations could render avian influenza virus
capable of becoming a pandemic strain. Genomewide
comparison of human versus avian influenza A viruses
would show the evolutionary similarities and differences
between them and thus provide information for studying
the mechanism of influenza viral infection and replication
in different host species.
Although many research efforts have focused on the
molecular evolution of specific genes of influenza viruses,
comprehensive comparisons among the nucleotide
sequences of all 8 genomic segments and among the 11
encoded protein sequences have not been extensively
reported. In this study, we used several computational
approaches for finding specific genetic signatures charac-
teristic of human and avian influenza Aviral genomes. We
subsequently validated the robustness of those signatures
with human and avian protein sequences downloaded from
Influenza Virus Resources at the National Center for
Biotechnology Information (NCBI) (http://www.ncbi.nlm.
nih. gov/genomes/FLU/FLU.html).
Materials and Methods
Clinical Isolates
Throat swabs from patients with influenzalike syn-
dromes were collected from the Clinical Virology
Laboratory, Chang Gung Memorial Hospital. The speci-
mens were inoculated in MDCK cells. Typing for influen-
za A virus was then performed with immunofluorescent
assay by type-specific monoclonal antibody (Dako,
Cambridgeshire, UK). Subtyping was conducted by
reverse transcription (RT)–PCR with subtype-specific
primers.
Sequence Analysis
The RT-PCR product was purified by using the
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA,
USA). The nucleotide sequence was determined with an
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ing were performed with Lasergene, version 3.18 (DNAS-
TAR, Madison, WI, USA). Multiple sequence alignment
was performed with ClustalW version 1.83 (ftp://ftp.
ebi.ac.uk/pub/software/unix/clustalw). Global sequence
comparison that yielded pairwise sequence identities used
in histogram analysis was done with the program Needle in
the EMBOSS package (5). Amino acid sequences were
translated from coding sequences and aligned by BioEdit
(6). An entropy value was defined at an aligned amino acid
position according to the formula ΣPi*log(Pi), in which i is
the observed probability for each of the 20 amino acids (aa)
(7). Agraphic tool was developed in Java for displaying the
entropy plot used in this work. All amino acid numberings
are based on influenza virus A/Puerto Rico/8/1934 (PR8).
Sequences Used in Study
To show the host-associated amino acid signatures, we
retrieved full genome sequences (as of August 22, 2005)
from the genome browser at Influenza Sequence Database
(ISD) (8). To differentiate between avian and human
influenza viruses, we excluded human-isolated avian
influenza viruses from the human dataset and examined
those sequences separately. Altogether, we had 95 avian
and 306 human influenza viral genomes, henceforth
termed “primary dataset.” All 11 viral proteins encoded by
the 8 genomic RNA segments were compared: PB2, PB1,
PB1-F2, PA, HA, NP, NA, M1, M2, NS1, and NS2.
Avian influenza viruses from human influenza patients
were separately retrieved from NCBI as well as from ISD.
Altogether, we had 417 protein sequences from 60 avian
influenza strains, in which 21 strains contain sequences
(full or nearly full length) from all 8 genomic RNA
segments.
For validating the signatures obtained from analyzing
the primary dataset, we further retrieved 15,785 human or
avian influenza A viral protein sequences from NCBI’s
Influenza Virus Resources. Details for the sequences used
can be found in online Appendix, Supporting Materials and
Methods (available from http://www.cdc.gov/ncidod/
EID/vol12no09/06-0276.htm#app), as well as in online
Appendix Table l (http://www.cdc.gov/ncidod/EID/vol12
no09/06-0276_appT1.htm) and online Appendix Table 2
(http://www.cdc.gov/ncidod/EID/vol12no09/06-0276_
appT2.htm). Eleven Taiwanese genomes produced in this
work have been deposited in GenBank with accession num-
bers DQ415283 through DQ415370. 
Results
Differing Amino Acid Residues
Using previously described methods (7), we separately
calculated an entropy value for every aligned amino acid
position for 95 avian influenza viruses and 306 human
influenza viruses. Those amino acid residues with an
entropy value between 0 and –0.4 for both the human and
avian strains were identified as most highly conserved. We
chose this entropy threshold on the basis of the entropy
value –0.379, calculated at position 627 of PB2 for the 95
avian viruses. This widely reported, species-associated
residue is highly conserved; it has E (Glu) in 83 and K
(Lys) in 12 avian isolates and Lys in all 306 human iso-
lates. We then selected those conserved positions with dis-
tinct amino acid residues between human and avian
influenza viruses as potential host-associated signatures.
An entropy plot for identifying such signature residues for
avian versus human influenza virus NP segments is shown
in Figure panel A. In each aligned position, we placed an
avian consensus residue on top and a human consensus at
the bottom. For example, the entropy value is zero at
amino acid position 283 for both avian and human strains,
in which all 95 avian influenza viruses contain L (Leu),
whereas all 306 human influenza viruses contain P (Pro).
The other 2 residues with zero entropy value in avian and
human viruses are located at position 55 of PA, in which
we have D (Asp) in avian viruses and N (Asn) in human
viruses, and position 121 of M1, in which we have T (Thr)
in avian and A(Ala) in human viruses. Entropy plots for all
11 influenza viral proteins can be found in online
Appendix Figure 1 (http://www.cdc.gov/ncidod/EID/
vol12no09/06-0276_appG1.htm).
Figure panel B shows a genomewide view of the
entropy plots for 11 influenza A viral proteins. The amino
acid sequences of hemagglutinin (HA), with an average
entropy value of –0.524 within avian viruses and –0.158
within human viruses, exhibit much more diversity than
other open reading frames (ORFs). PB2, PB1, PA, NP, and
M1, on the other hand, are more conserved (i.e., they have
less negative entropy values).
In addition to the previously mentioned 3 positions with
distinct amino acid residues between avian and human
strains, we found 225 additional positions with nearly dis-
tinct amino acid residues, with their computed entropy val-
ues less negative than –0.4 in both the 306 human and 95
avian strains that we analyzed. To assess the robustness of
those 228 residues used in differentiating human from
avian influenza viruses, we further examined 15,785
influenza A protein sequences from NCBI. After valida-
tion, 52 positions still showed an entropy value less nega-
tive than –0.4 and conserved to distinct amino acid
residues between human and avian viruses (Table 1). From
this entropy analysis, we identified an additional 51 aa
positions that may be as important as the well-known posi-
tion 627 of PB2. We designated these 52 positions as
“species-associated” signatures. Among 11 ORFs, NPcon-
tains the highest number of such signatures (15 positions),
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(5 positions), M2 (4 positions), M1 (3 positions), PB1 (2
positions), HA(2 positions), NS2 (2 positions), and NS1 (1
position). No signature was found in the NA gene. We also
summarized the related functions of those species-associ-
ated signatures in Table 1. The complete results of genome
scanning and validation can be found in online Appendix
Table 3 (http://www.cdc.gov/ncidod/EID/vol12no09/06-
0276_appT3.htm) and online Appendix Table 4 (http://
www.cdc.gov/ncidod/EID/vol12no09/06-0276_
appT4.htm). 
Amino Acid Signatures in Human Viruses
We examined how the amino acid sequences varied at
those proposed signature positions for avian influenza
viruses isolated from humans. At 9 of these 52 positions,
residue changes were characteristic of human rather than
avian viruses (Table 2). For example, 34 sequences (27
H5N1, 3 H9N2, and 4 H7N7) were available for inspection
at position 199 of PB2 (data not shown). Aside from 10
sequences with gaps (sequences did not cover this posi-
tion), 19 of the remaining 24 still have Ala, which is typi-
cal for avian viruses. Five of them (all H5N1), on the other
hand, have this residue changed to Ser, which is mostly
seen in human viruses. At the well-known position 627 of
PB2, 5 sequences had gaps, 22 retained Glu (typical for
avian virus), while the other 7 changed to Lys, which is
typical for human virus. Among those 7 mutated
sequences, 6 were from H5N1 human isolates (A/Hong
Kong/483/1997, A/Hong Kong/485/1997, A/Vietnam/
1194/ 2004, A/Vietnam/1203/2004, A/Vietnam/3062/2004,
and A/Thailand/16/2004), and the other 1 was A/
Netherlands/219/2003(H7N7), which was isolated from a
fatal human case of pneumonia in the Netherlands (32).
To understand how mutations had accumulated within a
specific virus, we summarized the amino acid changes for
21 of these avian viruses that contained full or nearly full-
length sequences for each segment (Table 3). We found that
19 of 21 strains contained >1 species-associated amino
acid change, and 7 of them contained >2 substitutions;
A/Netherlands/219/2003(H7N7) had the highest count for
mutation accumulation (3 positions). Among these 52
species-associated signatures, the mutation combinations
at positions PB2 199 and PA 409 were most commonly
seen in H5N1 human isolates from Hong Kong in 1997.
RNA Segment 5 
Our observation that NP contained the highest number
(15 of 52) for species-associated amino acids suggested
that NP might serve as a molecular target for differentia-
tion between human and avian influenza A viruses. To
indicate such host specificity, or the “genetic boundary”
Genomic Signatures, Influenza Viruses
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Figure. A) Entropy plot for avian versus human influenza
viruses for NP amino acid residues. In each aligned posi-
tion, we have a consensus residue for 95 avian strains
displayed on top and a consensus residue for 306
human strains at the bottom. Completely conserved
amino acid positions are filled with white; less conserved
amino acids are filled in various gray shadings. Positions
in which 1 single residue dominates >90%, <90% but
>75%, and <75% are labeled with red, yellow, and green
letters, respectively. Yellow rectangles indicate that both
human and avian viruses are completely conserved to
the same residue; magenta rectangles indicate that
avian and human viruses are each completely con-
served to a different residue. B) Entropy plots for the
entire influenza A viral genome. Each lane displays
entropy value distributions of aligned protein sequences
for 1 of the 11 viral proteins; the upper half represents 95
avian strains, and the bottom half represents 306 human
strains. (PB1-F2 contains fewer strains, as described in
Discussion.) Positions completely conserved to a single
residue are shown in a white band, while less conserved
ones are shown in various gray shadings. The average
entropy for the entire segment is shown to the right of
these lanes. Entropy values are zero when residues are
completely conserved; more negative values indicate
more diversity. Alignment size for each protein from top
to bottom is 759, 757, 90, 716, 591, 498, 480, 252, 97,
230, and 121.RESEARCH
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formed a pairwise sequence comparison for all 11 ORFs
on our 401-genome primary dataset and produced his-
tograms on their computed pairwise identities. In online
Appendix Figure 2 (http://www.cdc.gov/ncidod/EID/
vol12no09/06-0276_appG2.htm), pairs with 2 sequences
of the same host species (human to human, or avian to
avian; termed homopairs) and pairs for sequences that
cross host species (human to avian, or avian to human;
termed heteropairs) are shown. HA and NA genes exhibit-
ed considerable sequence differences between strains, with
identities as low as 47%. Also noted was a wide spectrum
of percent identities (e.g., 55%–95% in the horizontal axis)
containing few sequence pairs for these 2 genes. For both
of these proteins, some strains from the same species can
have identities as low as 50%. However, the ORF of anoth-
er surface protein, M2 ion channel protein, is relatively
conserved (>74% identity for viruses across species). The
histograms for the polymerase genes (PB2, PB1, and PA),
NP, and M1, on the other hand, are much less varied (most-
ly <20% variation). In particular, the NPgene was found to
exhibit a fairly clear boundary between homopairs and het-
eropairs, at ≈86%.
Discussion
The glutamic acid residue at PB2 627, which is com-
monly seen in avian viruses, restricts viral growth in
humans and monkeys, but a change to lysine restores virus
replication in mammalian cells (33). In this study we com-
puted for every amino acid position (distributed in the 11
known influenza viral ORFs) an entropy value that repre-
sents how conserved an amino acid residue is at that given
position. We found the entropy value –0.379 at 627 of PB2
and therefore used –0.4 as a threshold to discover other
amino acid residues that might be potential determinants of
Genomic Signatures, Influenza Viruses
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distinct or nearly distinct between human and avian virus-
es by this entropy threshold. Most of these (40 of 52) are
located in viral ribonucleoproteins (RNPs) (PB2, PB1, PA,
and NP), which are essential for viral replication.
Taubenberger et al. reported 10 amino acid residues that
distinguish human and avian influenza viral polymerases
(3). Six of them were also identified in this study. The
entropy values of the 4 missing ones were also found close
to the preset threshold (–0.4). For example, PB2 567
showed a human entropy of –0.039 and avian entropy of
–0.490, PB1 375 with human entropy –0.165 and avian
entropy –0.693, and PA 100 with human entropy –0.061
and avian entropy –0.406. All 3 positions were eliminated
earlier from the stage of analyzing the 401-genome pri-
mary dataset. The fourth position, PB2 702, although in the
first-round list, marginally failed in the subsequent valida-
tion with human entropy –0.057 and avian entropy –0.404.
We proposed a computational approach capable of indi-
cating species-associated signatures in studying human
versus avian influenza viral genomes. Although we intend-
ed to analyze a comprehensive set of avian versus human
influenza Aviral genomes, the available sequences are pre-
dominated by H5N1 in avian viruses and H3N2 in human
viruses. The short supply of sequences other than those 2
subtypes may inevitably cause a certain amount of bias in
our results. At the completion of this study, we noticed a
recent article by Obenauer et al., who had made 169 newly
sequenced avian influenza viral genomes available to
GenBank on January 26, 2006 (34); these were not includ-
ed in our analysis. We checked on our 52 signature posi-
tions against these new genomes and found only 2 of them
that showed an entropy value slightly over our threshold
–0.4. These are PB1-F2 87 and HA 237, with entropy val-
ues of –0.522, and –0.692, respectively. The choice of
entropy threshold would also affect the number of signa-
tures found. Originally we chose –0.4 on the basis of the
value –0.379, computed from PB2 627 by using 95 avian
genomes. We noticed that this entropy value reduced to
–0.299 at PB2 627 (see online Appendix Table 4) at the
later validation stage, when we found 197 E and 19 K from
a total of 215 avian PB2 sequences. If we chose to use a
more stringent entropy threshold of –0.3, our analysis still
showed 46 of those 52 reported signatures; missing were
positions 73, 79, and 82 from PB1-F2, 409 from PA, and
237 and 389 from HA. 
In addition to the data limitations, this approach of
looking for species-associated signatures by entropy is less
useful for HA and NA genes. The genetic diversity that
exists in either human or avian viruses for these 2 gene
segments can markedly boost their respective entropy to
more negative values, thus making it difficult to find
residues conserved enough for identifying such signatures.
We additionally performed the analysis on human H1, H2,
and H3 versus avian HA (online Appendix Figure 1). For
NA we performed the analysis on human N1 and N2 ver-
sus avian NA. We compared 10 human H1, 3 human H2,
and 293 human H3 with 95 avian HAsequences and found
13, 13, and 69 signatures (with entropy values for both
human and avian within –0.4), respectively. This finding
indicates that the human H1 and H2 strains are less distinct
from avian strains (H5 dominant) than H3. For NA we
found only 6 signatures, in comparison with 8 human N1
versus 95 avian (N1-dominant), and we found only 5 sig-
natures when we compared 298 human N2 and 95 avian
sequences. Entropy plots for these analyses can be seen in
online Appendix Figure 1.
Two genetic alleles (allele A and B) have been
described for the NS gene in avian influenza A virus. We
decomposed those 95 avian NS genes into 43 in allele A
and 52 in allele B and compared their amino acid
sequences with 306 human NS genes. For NS1, 6 signa-
tures were found between human viruses and avian allele
A viruses, and 35 signatures were found between human
viruses and avian allele B viruses. For NS2, 3 signatures
were found between human viruses and allele A viruses,
and 6 signatures were found between human viruses and
allele B viruses. These results suggest that avian allele B
viruses are more distinct from human viruses than are
allele A viruses. Entropy plots and histograms for these
analyses can be seen in online Appendix Figure 1 and
online Appendix Figure 3 (http://www.cdc.gov/ncidod/
EID/vol12no09/06-0276_appG3.htm). 
From the histograms, we found that some of the 11
genes vary greatly between human and avian viruses,
while some others vary little. No boundaries were found
between homopairs and heteropairs for HA, NA, and PB1
for human versus avian viruses. This finding seems rea-
sonable because the 2 recent pandemic strains, the 1957
H2N2 and the 1968 H3N2, both originated from reassort-
ment with avian influenza viruses (HA, NA, and PB1 gene
segments were from avian influenza). On the other hand,
because histograms of NP, followed by PA and PB2, may
be used to distinguish human influenza viruses from avian
influenza viruses, perhaps some biologic constraints
against the occurrence of reassortment exist for these 3
genes. Both the M and NS genes are less differentiable
between these 2 types of influenza A viruses.
NP not only displays a clear boundary between human
and avian viruses from histogram analysis but also con-
tains more species-associated amino acid signatures (15 of
52) than other ORFs. In addition to NP, polymerase pro-
teins PB2, PB1, and PA also contain abundant species-
associated signatures. Most signatures in these viral RNPs
are located on the functional domains related to RNP-
RNP interactions that are necessary to form replicase/
RESEARCH
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specific combinations of polymerase complex and NP
would allow an influenza virus to replicate itself efficient-
ly (Table 1). In addition to RNA-interacting domains,
many species-associated amino acid signatures of 3P and
NP are located in regions related to nuclear localization
signals. Influenza viral replication is highly dependent on
nuclear function (35), making it worthwhile to further
examine the roles of those amino acid signatures on
nuclear localization of viral RNP in avian versus human
cells. We also noticed that several amino acid signatures in
NPare located in the regions that interact with cellular pro-
teins, such as splicing factor (BAT1/UAP56) or MxA,
which plays a certain role in cellular antiviral mechanisms.
What species-specific host factors may affect influenza
viral replication rates is not clear. Biologic experiments are
required for further understanding the roles of those amino
acid residues and related functional domains in the mech-
anism of interspecies infection.
PB1-F2 is a novel influenza viral protein translated
from alternative initiation of PB1 gene. PB1-F2 of PR8
(H1N1) has been shown to target mitochondria and then
trigger host cell apoptosis (36). Our previous research has
found that several strains contain truncated PB1-F2 (37).
In this study, 379 of 401 PB1 sequences (in the primary
dataset) contained PB1-F2 >87 and <90 aa. For the other
22 sequences, 2 H3N2 strains missed a start codon, 3
H3N2 had the translation stopped at 11 aa, 1 H9N2
stopped at 8 aa, 5 H1N1 stopped at 57 aa, and 3 H9N2 and
7 H3N2 stopped at 79 aa. One H5N1 contained extra
residues; its PB1-F2 was 101 aa. We also noted 5 species-
associated signatures on PB1-F2; all of them are within the
C-terminal domain, which is important for mitochondria
targeting (15,16). Further investigation of the mitochon-
dria localization of those PB1-F2 variants and their abili-
ties for triggering apoptosis in cells derived from different
species is warranted.
How many mutations would make an avian virus capa-
ble of infecting humans efficiently, or how many mutations
would render an influenza virus a pandemic strain, is diffi-
cult to predict. We have examined sequences from the
1918 strain, which is the only pandemic influenza virus
that could be entirely derived from avian strains. Of the 52
species-associated positions, 16 have residues typical for
human strains; the others remained as avian signatures.
The result supports the hypothesis that the 1918 pandemic
virus is more closely related to the avian influenza A virus
than are other human influenza viruses (2). From the 21
avian viruses isolated from humans in this study, we found
19 (90.5%) that contain >1 change at the species-associat-
ed sites. Upon examining signature changes from similar-
ly sized sets of randomly selected human viruses,
randomly selected avian viruses, and randomly selected
viruses (avian plus human), we found 29.4%, 71.4%, and
47.1%, respectively, contain species-associated mutations.
Although predicting the emergence of a pandemic strain is
difficult, close monitoring of how those species-associated
signature positions have changed from bird-specific to
human-specific signatures may provide a measurement for
the prediction of such events.
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